HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valerie G Brunton Selected Research

AZD-0424

1/2022Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valerie G Brunton Research Topics

Disease

52Neoplasms (Cancer)
07/2022 - 06/2004
17Breast Neoplasms (Breast Cancer)
01/2022 - 10/2009
9Neoplasm Metastasis (Metastasis)
01/2018 - 01/2005
8Colonic Neoplasms (Colon Cancer)
09/2008 - 08/2002
4Carcinogenesis
01/2018 - 02/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2017 - 02/2009
2Lobular Carcinoma
10/2021 - 10/2018
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2020 - 02/2012
2Prostatic Neoplasms (Prostate Cancer)
01/2018 - 05/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 08/2013
2Papilloma (Papillomatosis)
12/2012 - 02/2009
2Carcinoma (Carcinomatosis)
12/2006 - 02/2005
2autosomal recessive 1 Spinocerebellar ataxia
01/2006 - 12/2004
1Triple Negative Breast Neoplasms
01/2022
1Bites and Stings (Sting)
01/2019
1Hemangiosarcoma (Angiosarcoma)
01/2019
1Poikiloderma of Kindler
01/2019
1Sarcoma (Soft Tissue Sarcoma)
01/2019
1Lymphoma (Lymphomas)
01/2019
1Melanoma (Melanoma, Malignant)
12/2018
1Hypersensitivity (Allergy)
01/2018
1Kidney Neoplasms (Kidney Cancer)
01/2017
1Metaplasia
08/2013
1Bone Diseases (Bone Disease)
05/2013
1Osteolysis
05/2013
1Residual Neoplasm
02/2012
1Osteosarcoma (Osteogenic Sarcoma)
07/2011

Drug/Important Bio-Agent (IBA)

14src-Family KinasesIBA
01/2022 - 06/2004
12Phosphotransferases (Kinase)IBA
01/2022 - 10/2004
10Focal Adhesion Protein-Tyrosine KinasesIBA
07/2022 - 02/2005
10Pharmaceutical PreparationsIBA
01/2022 - 10/2004
10Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2004
9IntegrinsIBA
01/2018 - 08/2002
7Cadherins (E-Cadherin)IBA
10/2018 - 08/2002
6Dasatinib (BMS 354825)FDA Link
08/2013 - 12/2006
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 09/2011
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 01/2011
3Biomarkers (Surrogate Marker)IBA
11/2020 - 12/2006
3Lapatinib (GW572016)FDA Link
02/2020 - 08/2014
3human ERBB2 proteinIBA
03/2016 - 10/2009
2Biological ProductsIBA
10/2021 - 01/2021
2Estrogen Receptor alphaIBA
01/2021 - 11/2020
2Transcription Factors (Transcription Factor)IBA
01/2017 - 01/2017
2AZD 8931IBA
03/2016 - 02/2016
2LigandsIBA
09/2015 - 05/2013
2Tyrosine Kinase InhibitorsIBA
05/2013 - 07/2011
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2006 - 10/2004
1Insulin-Like Growth Factor I (IGF-1)IBA
02/2022
1integrin-linked kinaseIBA
01/2022
1bosutinibIBA
01/2022
1AZD-0424IBA
01/2022
1UbiquitinIBA
11/2021
1Estrogen ReceptorsIBA
10/2021
1Fulvestrant (Faslodex)FDA Link
01/2021
1ponatinibIBA
12/2020
1IronIBA
02/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1cadherin 5IBA
01/2019
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2019
1nifuroxazide (Akabar)IBA
12/2018
1ProdrugsIBA
12/2018
1EnzymesIBA
12/2018
1Aldehyde DehydrogenaseIBA
12/2018
1Anti-Bacterial Agents (Antibiotics)IBA
12/2018
1Antineoplastic Agents (Antineoplastics)IBA
10/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2018
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018
1RibonucleotidesIBA
01/2018
1TenascinIBA
01/2018
1Tumor Viral Antigens (Large T Antigen)IBA
01/2018
1Ribonucleases (Ribonuclease)IBA
01/2018
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2018
1Insulin-Like Growth Factor Binding Protein 3IBA
10/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1Docetaxel (Taxotere)FDA Link
01/2017
1Axl Receptor Tyrosine KinaseIBA
01/2016
1PND 1186IBA
09/2015
1ChemokinesIBA
09/2015
1AntigensIBA
09/2015
1CytokinesIBA
09/2015
1Lysophosphatidic Acid ReceptorsIBA
10/2014
1GTP-Binding Proteins (G-Protein)IBA
10/2014
1Trastuzumab (Herceptin)FDA Link
08/2014
1Fluorouracil (Carac)FDA LinkGeneric
01/2014
1PalladiumIBA
01/2014
1Insulin-Like PeptidesIBA
05/2013
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
05/2013
1Macrophage Colony-Stimulating FactorIBA
05/2013
1Insulin (Novolin)FDA Link
05/2013
1Phorbol EstersIBA
12/2012
1matriptaseIBA
01/2012
1lenvatinibIBA
07/2011
1Fluorescent Dyes (Fluorescent Probes)IBA
07/2011
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
07/2011
1ActomyosinIBA
06/2011
1CarcinogensIBA
06/2011

Therapy/Procedure

16Therapeutics
01/2022 - 05/2009
2Drug Therapy (Chemotherapy)
01/2017 - 10/2004
1Lasers (Laser)
02/2022